Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-04-11

AUTHORS

Yoshiteru Soejima, Robert P Ostrowski, Anatol Manaenko, Mutsumi Fujii, Jiping Tang, John H Zhang

ABSTRACT

BACKGROUND: Hemorrhagic transformation (HT) can be a devastating complication of ischemic stroke. Hyperbaric oxygen preconditioning (HBO-PC) has been shown to improve blood-brain barrier (BBB) permeability in stroke models. The purpose of this study is to examine whether HBO-PC attenuates HT after focal cerebral ischemia, and to investigate whether the mechanism of HBO-PC against HT includes up-regulation of antioxidants in hyperglycemic rats. METHODS: Male Sprague-Dawley rats (280-320 g) were divided into the following groups: sham, middle cerebral artery occlusion (MCAO) for 2 h, and MCAO treated with HBO-PC. HBO-PC was conducted giving 100% oxygen at 2.5 atm absolute (ATA), for 1 h at every 24 h interval for 5 days. At 24 h after the last session of HBO-PC, rats received an injection of 50% glucose (6 ml/kg intraperitoneally) and were subjected to MCAO 15 min later. At 24 h after MCAO, neurological behavior tests, infarct volume, blood-brain barrier permeability, and hemoglobin content were measured to evaluate the effect of HBO-PC. Western blot analysis of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) was evaluated at multiple time-points before and after MCAO. RESULTS: HBO-PC improved neurological behavior test, and reduced infarction volume, HT and Evans blue extravasation in the ipsilateral hemisphere at 24 h after MCAO. Western blot analysis failed to demonstrate up-regulation of Nrf2 in HBO-PC group before and after MCAO. Paradoxically, HBO-PC decreased HO-1 expression at 24 h after MCAO, as compared with htMCAO group. CONCLUSIONS: HBO-PC improved neurological deficits, infarction volume, BBB disruption, and HT after focal cerebral ischemia. However, its mechanism against focal cerebral ischemia and HT may not include activation of Nrf2 and subsequent HO-1 expression. More... »

PAGES

9-9

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/2045-9912-2-9

DOI

http://dx.doi.org/10.1186/2045-9912-2-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043367746

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22494892


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.43582.38", 
          "name": [
            "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soejima", 
        "givenName": "Yoshiteru", 
        "id": "sg:person.0700543354.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700543354.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.43582.38", 
          "name": [
            "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ostrowski", 
        "givenName": "Robert P", 
        "id": "sg:person.01140214600.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140214600.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.43582.38", 
          "name": [
            "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manaenko", 
        "givenName": "Anatol", 
        "id": "sg:person.01243404716.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243404716.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.43582.38", 
          "name": [
            "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fujii", 
        "givenName": "Mutsumi", 
        "id": "sg:person.01307721054.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307721054.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.43582.38", 
          "name": [
            "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tang", 
        "givenName": "Jiping", 
        "id": "sg:person.01266316210.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266316210.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.43582.38", 
          "name": [
            "Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "John H", 
        "id": "sg:person.010237001360.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010237001360.90"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10571-004-1378-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021903399", 
          "https://doi.org/10.1007/s10571-004-1378-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-211-09469-3_37", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033411323", 
          "https://doi.org/10.1007/978-3-211-09469-3_37"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004240100571", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048157802", 
          "https://doi.org/10.1007/s004240100571"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12192-009-0159-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016103527", 
          "https://doi.org/10.1007/s12192-009-0159-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-211-98811-4_7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011134859", 
          "https://doi.org/10.1007/978-3-211-98811-4_7"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-04-11", 
    "datePublishedReg": "2012-04-11", 
    "description": "BACKGROUND: Hemorrhagic transformation (HT) can be a devastating complication of ischemic stroke. Hyperbaric oxygen preconditioning (HBO-PC) has been shown to improve blood-brain barrier (BBB) permeability in stroke models. The purpose of this study is to examine whether HBO-PC attenuates HT after focal cerebral ischemia, and to investigate whether the mechanism of HBO-PC against HT includes up-regulation of antioxidants in hyperglycemic rats.\nMETHODS: Male Sprague-Dawley rats (280-320 g) were divided into the following groups: sham, middle cerebral artery occlusion (MCAO) for 2 h, and MCAO treated with HBO-PC. HBO-PC was conducted giving 100% oxygen at 2.5 atm absolute (ATA), for 1 h at every 24 h interval for 5 days. At 24 h after the last session of HBO-PC, rats received an injection of 50% glucose (6 ml/kg intraperitoneally) and were subjected to MCAO 15 min later. At 24 h after MCAO, neurological behavior tests, infarct volume, blood-brain barrier permeability, and hemoglobin content were measured to evaluate the effect of HBO-PC. Western blot analysis of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) was evaluated at multiple time-points before and after MCAO.\nRESULTS: HBO-PC improved neurological behavior test, and reduced infarction volume, HT and Evans blue extravasation in the ipsilateral hemisphere at 24 h after MCAO. Western blot analysis failed to demonstrate up-regulation of Nrf2 in HBO-PC group before and after MCAO. Paradoxically, HBO-PC decreased HO-1 expression at 24 h after MCAO, as compared with htMCAO group.\nCONCLUSIONS: HBO-PC improved neurological deficits, infarction volume, BBB disruption, and HT after focal cerebral ischemia. However, its mechanism against focal cerebral ischemia and HT may not include activation of Nrf2 and subsequent HO-1 expression.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/2045-9912-2-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2562186", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1045395", 
        "issn": [
          "2045-9912"
        ], 
        "name": "Medical Gas Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "2"
      }
    ], 
    "keywords": [
      "middle cerebral artery occlusion", 
      "focal cerebral ischemia", 
      "blood-brain barrier permeability", 
      "neurological behavior tests", 
      "hemorrhagic transformation", 
      "hyperbaric oxygen preconditioning", 
      "HBO-PC", 
      "HO-1 expression", 
      "cerebral ischemia", 
      "heme oxygenase-1", 
      "Western blot analysis", 
      "infarction volume", 
      "barrier permeability", 
      "transient middle cerebral artery occlusion", 
      "male Sprague-Dawley rats", 
      "HBO-PC group", 
      "cerebral artery occlusion", 
      "Evans blue extravasation", 
      "Sprague-Dawley rats", 
      "behavior tests", 
      "blot analysis", 
      "regulation of Nrf2", 
      "BBB disruption", 
      "devastating complication", 
      "infarct volume", 
      "neurological deficits", 
      "ischemic stroke", 
      "artery occlusion", 
      "ipsilateral hemisphere", 
      "hyperglycemic rats", 
      "stroke model", 
      "oxygenase-1", 
      "ischemia", 
      "rats", 
      "nuclear factor", 
      "hemoglobin content", 
      "last session", 
      "factor 2", 
      "regulation of antioxidants", 
      "preconditioning", 
      "group", 
      "complications", 
      "hyperglycemia", 
      "sham", 
      "extravasation", 
      "expression", 
      "stroke", 
      "Nrf2", 
      "occlusion", 
      "injection", 
      "volume", 
      "deficits", 
      "activation", 
      "regulation", 
      "days", 
      "antioxidants", 
      "glucose", 
      "test", 
      "sessions", 
      "min", 
      "mechanism", 
      "disruption", 
      "intervals", 
      "factors", 
      "study", 
      "hemisphere", 
      "permeability", 
      "effect", 
      "analysis", 
      "purpose", 
      "content", 
      "model", 
      "oxygen", 
      "transformation", 
      "atm", 
      "oxygen preconditioning", 
      "MCAO 15 min", 
      "blue extravasation", 
      "htMCAO group", 
      "subsequent HO-1 expression"
    ], 
    "name": "Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats", 
    "pagination": "9-9", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043367746"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/2045-9912-2-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22494892"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/2045-9912-2-9", 
      "https://app.dimensions.ai/details/publication/pub.1043367746"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_558.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/2045-9912-2-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/2045-9912-2-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/2045-9912-2-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/2045-9912-2-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/2045-9912-2-9'


 

This table displays all metadata directly associated to this object as RDF triples.

198 TRIPLES      22 PREDICATES      111 URIs      98 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/2045-9912-2-9 schema:about anzsrc-for:11
2 anzsrc-for:1109
3 schema:author N1efd1126a72c44b3b0570bbd431d7abf
4 schema:citation sg:pub.10.1007/978-3-211-09469-3_37
5 sg:pub.10.1007/978-3-211-98811-4_7
6 sg:pub.10.1007/s004240100571
7 sg:pub.10.1007/s10571-004-1378-7
8 sg:pub.10.1007/s12192-009-0159-0
9 schema:datePublished 2012-04-11
10 schema:datePublishedReg 2012-04-11
11 schema:description BACKGROUND: Hemorrhagic transformation (HT) can be a devastating complication of ischemic stroke. Hyperbaric oxygen preconditioning (HBO-PC) has been shown to improve blood-brain barrier (BBB) permeability in stroke models. The purpose of this study is to examine whether HBO-PC attenuates HT after focal cerebral ischemia, and to investigate whether the mechanism of HBO-PC against HT includes up-regulation of antioxidants in hyperglycemic rats. METHODS: Male Sprague-Dawley rats (280-320 g) were divided into the following groups: sham, middle cerebral artery occlusion (MCAO) for 2 h, and MCAO treated with HBO-PC. HBO-PC was conducted giving 100% oxygen at 2.5 atm absolute (ATA), for 1 h at every 24 h interval for 5 days. At 24 h after the last session of HBO-PC, rats received an injection of 50% glucose (6 ml/kg intraperitoneally) and were subjected to MCAO 15 min later. At 24 h after MCAO, neurological behavior tests, infarct volume, blood-brain barrier permeability, and hemoglobin content were measured to evaluate the effect of HBO-PC. Western blot analysis of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) was evaluated at multiple time-points before and after MCAO. RESULTS: HBO-PC improved neurological behavior test, and reduced infarction volume, HT and Evans blue extravasation in the ipsilateral hemisphere at 24 h after MCAO. Western blot analysis failed to demonstrate up-regulation of Nrf2 in HBO-PC group before and after MCAO. Paradoxically, HBO-PC decreased HO-1 expression at 24 h after MCAO, as compared with htMCAO group. CONCLUSIONS: HBO-PC improved neurological deficits, infarction volume, BBB disruption, and HT after focal cerebral ischemia. However, its mechanism against focal cerebral ischemia and HT may not include activation of Nrf2 and subsequent HO-1 expression.
12 schema:genre article
13 schema:inLanguage en
14 schema:isAccessibleForFree true
15 schema:isPartOf N42f94a826426459ca530adb0b2b28188
16 N902301f30ba24d2299d9aad0800e191e
17 sg:journal.1045395
18 schema:keywords BBB disruption
19 Evans blue extravasation
20 HBO-PC
21 HBO-PC group
22 HO-1 expression
23 MCAO 15 min
24 Nrf2
25 Sprague-Dawley rats
26 Western blot analysis
27 activation
28 analysis
29 antioxidants
30 artery occlusion
31 atm
32 barrier permeability
33 behavior tests
34 blood-brain barrier permeability
35 blot analysis
36 blue extravasation
37 cerebral artery occlusion
38 cerebral ischemia
39 complications
40 content
41 days
42 deficits
43 devastating complication
44 disruption
45 effect
46 expression
47 extravasation
48 factor 2
49 factors
50 focal cerebral ischemia
51 glucose
52 group
53 heme oxygenase-1
54 hemisphere
55 hemoglobin content
56 hemorrhagic transformation
57 htMCAO group
58 hyperbaric oxygen preconditioning
59 hyperglycemia
60 hyperglycemic rats
61 infarct volume
62 infarction volume
63 injection
64 intervals
65 ipsilateral hemisphere
66 ischemia
67 ischemic stroke
68 last session
69 male Sprague-Dawley rats
70 mechanism
71 middle cerebral artery occlusion
72 min
73 model
74 neurological behavior tests
75 neurological deficits
76 nuclear factor
77 occlusion
78 oxygen
79 oxygen preconditioning
80 oxygenase-1
81 permeability
82 preconditioning
83 purpose
84 rats
85 regulation
86 regulation of Nrf2
87 regulation of antioxidants
88 sessions
89 sham
90 stroke
91 stroke model
92 study
93 subsequent HO-1 expression
94 test
95 transformation
96 transient middle cerebral artery occlusion
97 volume
98 schema:name Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats
99 schema:pagination 9-9
100 schema:productId N22190bc7b8054537bb5362b0ded63711
101 N4331b1031a4843e58bd3a288a6da6464
102 N94f91a80e0d84cf48805668751be254b
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043367746
104 https://doi.org/10.1186/2045-9912-2-9
105 schema:sdDatePublished 2022-01-01T18:27
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher N916ab89f11884b5a948bfda5643eda75
108 schema:url https://doi.org/10.1186/2045-9912-2-9
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N1e6ee100697c4a17bcb47c043c881920 rdf:first sg:person.01243404716.16
113 rdf:rest N33e6cc8937224a48ae3317db038d68f6
114 N1efd1126a72c44b3b0570bbd431d7abf rdf:first sg:person.0700543354.34
115 rdf:rest Nc0956481f56f41178340e9cf44f26933
116 N22190bc7b8054537bb5362b0ded63711 schema:name dimensions_id
117 schema:value pub.1043367746
118 rdf:type schema:PropertyValue
119 N33e6cc8937224a48ae3317db038d68f6 rdf:first sg:person.01307721054.12
120 rdf:rest N5c2d0f22ecc74f7b894e1361b2887551
121 N42f94a826426459ca530adb0b2b28188 schema:issueNumber 1
122 rdf:type schema:PublicationIssue
123 N4331b1031a4843e58bd3a288a6da6464 schema:name doi
124 schema:value 10.1186/2045-9912-2-9
125 rdf:type schema:PropertyValue
126 N5c2d0f22ecc74f7b894e1361b2887551 rdf:first sg:person.01266316210.51
127 rdf:rest N87acbda7f7a54ea3bac70dacc6f50205
128 N87acbda7f7a54ea3bac70dacc6f50205 rdf:first sg:person.010237001360.90
129 rdf:rest rdf:nil
130 N902301f30ba24d2299d9aad0800e191e schema:volumeNumber 2
131 rdf:type schema:PublicationVolume
132 N916ab89f11884b5a948bfda5643eda75 schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 N94f91a80e0d84cf48805668751be254b schema:name pubmed_id
135 schema:value 22494892
136 rdf:type schema:PropertyValue
137 Nc0956481f56f41178340e9cf44f26933 rdf:first sg:person.01140214600.24
138 rdf:rest N1e6ee100697c4a17bcb47c043c881920
139 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
140 schema:name Medical and Health Sciences
141 rdf:type schema:DefinedTerm
142 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
143 schema:name Neurosciences
144 rdf:type schema:DefinedTerm
145 sg:grant.2562186 http://pending.schema.org/fundedItem sg:pub.10.1186/2045-9912-2-9
146 rdf:type schema:MonetaryGrant
147 sg:journal.1045395 schema:issn 2045-9912
148 schema:name Medical Gas Research
149 schema:publisher Springer Nature
150 rdf:type schema:Periodical
151 sg:person.010237001360.90 schema:affiliation grid-institutes:grid.43582.38
152 schema:familyName Zhang
153 schema:givenName John H
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010237001360.90
155 rdf:type schema:Person
156 sg:person.01140214600.24 schema:affiliation grid-institutes:grid.43582.38
157 schema:familyName Ostrowski
158 schema:givenName Robert P
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140214600.24
160 rdf:type schema:Person
161 sg:person.01243404716.16 schema:affiliation grid-institutes:grid.43582.38
162 schema:familyName Manaenko
163 schema:givenName Anatol
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243404716.16
165 rdf:type schema:Person
166 sg:person.01266316210.51 schema:affiliation grid-institutes:grid.43582.38
167 schema:familyName Tang
168 schema:givenName Jiping
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266316210.51
170 rdf:type schema:Person
171 sg:person.01307721054.12 schema:affiliation grid-institutes:grid.43582.38
172 schema:familyName Fujii
173 schema:givenName Mutsumi
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307721054.12
175 rdf:type schema:Person
176 sg:person.0700543354.34 schema:affiliation grid-institutes:grid.43582.38
177 schema:familyName Soejima
178 schema:givenName Yoshiteru
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700543354.34
180 rdf:type schema:Person
181 sg:pub.10.1007/978-3-211-09469-3_37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033411323
182 https://doi.org/10.1007/978-3-211-09469-3_37
183 rdf:type schema:CreativeWork
184 sg:pub.10.1007/978-3-211-98811-4_7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011134859
185 https://doi.org/10.1007/978-3-211-98811-4_7
186 rdf:type schema:CreativeWork
187 sg:pub.10.1007/s004240100571 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048157802
188 https://doi.org/10.1007/s004240100571
189 rdf:type schema:CreativeWork
190 sg:pub.10.1007/s10571-004-1378-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021903399
191 https://doi.org/10.1007/s10571-004-1378-7
192 rdf:type schema:CreativeWork
193 sg:pub.10.1007/s12192-009-0159-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016103527
194 https://doi.org/10.1007/s12192-009-0159-0
195 rdf:type schema:CreativeWork
196 grid-institutes:grid.43582.38 schema:alternateName Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA
197 schema:name Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA
198 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...